
Keywords: 2-AG; 2-arachidonoylglycerol; ALK; anaplastic lymphoma kinase; ATF-4; activating transcription factor 4; CB1; cannabinoid CB1 receptor; CB2; cannabinoid CB2 receptor; CBD; cannabidiol; CHOP; C/EBP homologous protein; EGFR; epidermal growth factor receptor